A semiquantitative cortical circumferential normalization method for clinical evaluation of rCBF brain SPECT

Clinical Nuclear Medicine

Volumn 22, Issue 9, 1997, Pages 596-604

  Liu, Hong Gang ^a   Mountz, James M ^a   Inampudi, Chakri ^a   San Pedro, Elmer C ^a   Deutsch, Georg ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Brain; rCBF; Semiquantitative; SPECT; Tc 99m HMPAO

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOMATION; BRAIN BLOOD FLOW; BRAIN REGION; BRAIN SCINTISCANNING; CONTROLLED STUDY; DATA BASE; EARLY DIAGNOSIS; HUMAN; HUMAN EXPERIMENT; IMAGE RECONSTRUCTION; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; NORMAL VALUE; QUANTITATIVE DIAGNOSIS; SCHOOL CHILD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; AGED; AGING; ALZHEIMER DISEASE; BRAIN DISEASES; CASE-CONTROL STUDIES; CEREBELLUM; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; CHILD; CORPUS CALLOSUM; FRONTAL LOBE; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MIDDLE AGED; PARIETAL LOBE; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031461038     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199709000-00004     Document Type: Article

References (23)

1. Mountz JM: Quantification of the SPECT brain scan. Nuclear Medicine Annual: 1991:67-98. (Leonard M. Freeman - Editor) Raven Press, New York.
2. Lassen NA, Andersen AR, Friberg L, Paulson OB: The retention of [99m Tc]-d,1-HMPAO in the human brain intracarotid bolus injection: A kinetic analysis. J Cereb Blood Flow Metab 8:S13, 1988.
3. Johnson KA, Kijewski MF, Becker JA, Garada B, Satlin A, Hol- man BL: Quantitative brain SPECT in Alzheimer's disease and normal aging. J Nucl Med 34:2044, 1993.
4. Rosenthal MS, Cullom J, Hawkins W, Moore SC, Tsui BMW, Yester M: Quantitative SPECT imaging; A review and recommendations by the Focus Committee of the Society of Nuclear Medicine Computer and Instrumentation Council. J Nucl Med 36:1489, 1995.
5. Hellman RS, Tikofsky RS, Collier BD, et al: Alzheimer disease: Quantitative analysis of I-123-Iodoamphetamine SPECT brain imaging. Radiology 172:183, 1989.
6. Friedman PJ, Davis G, Allen B: Semi-quantitative SPECT scanning in acute ischemic stroke. Scand J Rehab Med 25:99, 1993.
7. Hellman RS, Tikofsky RS, Van Heertum R, Coade G, Carretta R, Hoffmann RG: A Multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPECT technetium-99m exametazime (HMPAO). Eur J Nucl Med 21:306, 1994.
8. Bonte FJ, Tintner R, Weiner MF, Bigio EH, White III CL: Brain blood flow in the dementia: SPECT with histopathologic correlation. Radiology 186:361, 1993.
9. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A: The scintigraphic appearance of Alzheimer's disease: A prospective study using Technetium-99m-HMPAO SPECT. J Nucl Med 33:181, 1992.
10. Perani D, DiPiero V, Vallar G, et al: Technetium-99m HM-PAO SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med 29:1507, 1988.
11. Rango M, Candelise L, Perani D, et al: Cortical pathophysiology and clinical neurologic abnormalities in acute cerebral ischemia. Arch Neurol 46:1318, 1989.
12. Reischies FM, Hedde J-P, Gutzmann H: The investigation of dementia syndromes by 133-Xe dynamic single photon emission computed tomography. Neurosurg Rev 10:105, 1987.
13. Links JM, Devous MD: Three-dimensional display in nuclear medicine: A more useful depiction of reality, or only a superficial rendering? J Nucl Med 36:703, 1995.
14. Mountz JM, Wilson MW, Wolf CG, Deutsch G, Harris JM: Validation of a reference method for correlation of anatomic and functional brain images. Comp Med Image Graphics 18:163, 1994.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939, 1984.
16. Mountz JM, Tolbert LC, Lill DW, Katholi CR, Liu HG: Functional deficits in autistic disorder: Characterization by Technetium-99m-HMPAO and SPECT. J Nucl Med 7:1156, 1995.
17. Liu HG, Harris JM, Inampudi CS, Mountz JM: Optimal reconstruction filter parameters for multi-headed brain SPECT: Dependence on count activity. J Nucl Med Technol 23:251, 1995.
18. Chang LT: A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 26:638, 1978.
19. Mountz JM, Zhang B, Liu HG, Inampudi C: A reference method for correlation of anatomic and functional brain images: Validation and clinical application. Semin Nucl Med 24:256, 1994.
20. Gemmell HG, Sharp PF, Besson JA, et al: Differential diagnosis in dementia using the cerebral blood flow agent 99mTc- HM-PAO: A SPECT study. J Comput Assist Tomogr 11:398, 1987.
21. Smith FW, Besson JA, Gemmell HG, Sharp PF: The use of technetium-99m-HMPAO in the assessment of patients with dementia and other neuropsychiatric conditions. J Cereb Blood Flow Metab 8:116, 1988.
22. Hirano T, Minematsu K, Hasegawa Y, et al: Acetazolamide reactivity on 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: Correlation with positron emission tomography parameters. J Cereb Blood Flow Metab 14:763, 1994.
23. Bonte FJ, Devous MD, Reisch JS, et al:Ajmani AK, Weiner MF, Horn J, Tintner R. The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer's disease or stroke as measured by single photon emission computed tomography. J Invest Radiol 24:99, 1989.